(Q42932965)

English

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study

scientific article published on December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Christoph Baerwald

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Paolo Verdecchia

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Brigitte Duquesroix

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Hayet Frayssinet

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Thierry Ferreira

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

3635-3644

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Musculoskeletal aging

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Disabling knee pain--another consequence of obesity: results from a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I).

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Risk factors for the development of hip osteoarthritis: a population-based prospective study

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Nitric oxide in mucosal defense: a little goes a long way.

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Role of nitric oxide in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

NSAIDs and blood pressure. Clinical importance for older patients

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FART.27694

21 January 2018

Identifiers

10.1002/ART.27694

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42932965&oldid=1974033090"